Nusayba Anjarwalla, Engagement Manager, Global Pricing, Market Access And Analytics Line, Precision Xtract
Katerina Anokhina, Director, Medical Affairs, Uk And Ireland, Alexion Pharma UK
Diego Ardigo, Research And Development Rare Diseases Unit Head, Chiesi Farmaceutici SpA
Francis Arickx, Head Of The Directorate Reimbursement Of Medicines And Pharmaceutical Policy, National Institute for Health and Disability Insurance RIZIV-INAMI
Nadeem Ashraf, Medical Advisor - Diabetes, N/A
Matthew Bending, Senior Principal And Executive Director Of Hta Strategy, Market Access Consulting, Evidera
Kevin Mayo, Head, Global Market Access - New Products, Shire Pharmaceuticals
Elizabeth Mckenna, Head Of Market Access Uk And Ireland, Vertex Pharmaceuticals
Paul Mcloughlin, Vice President Of Market Access & Phase Iv Solutions, Covance
Soniya Mokashi, Global Senior Medical Affairs Physician, Norgine
Patrick Mollon, Former Director Gheore, Ipsen Pharma
Tal Morginstin, Director, Nlhs (National List Of Health Services) Assessment Division, Ministry of Health
Thomas Mueller, Head Of Directorate General 1 "Drugs, Medical Devices, Biotechnology", Federal Ministry of Health Germany
Diane Munch, Head Of Global Pricing, Patient And Health Impact, Pfizer
Sue Naeyaert, Vice President Global Government Affairs, Policy And Pharmacoeconomics Biosimilars, Fresenius Kabi
Alexander Natz, Secretary General, European Confederation of Pharmaceutical Entrepreneurs (Belgium)
Elsa Navarro, Senior Advisor, Evidera
Waldemar Ockert, Director, Rwi Business Market Analytics, Astellas Pharma
Irina Odnoletkova, Vice President Health Technology Assessment, Apogenix Gmbh
Laura O'Hanlon, Associate Director, International Market Access/Reimbursement, Myriad genetics
Vitaly Omelyanovskiy, General Director, Center Of Healthcare Quality Assessment And Control, Federal State Budgetary Institution, the Center for Healthcare Quality Assessment and Control of the Ministry of Health of the R
Nneka Onwudiwe, Founder And Chief Executive Officer, Pharmacoeconomics Consultants of America
Mario Ouwens, Statistical Science Director, Astra Zeneca
Melissa Paige, Uva Cancer Center, Oncology Patient Access Principal Coordinator, Patient Advocate, U.V.A. Health System
Ana Palma, Senior Director Global Hta And Patient Access Lead, Sobi
Elena Panitti, Global Rwe Capability Building Lead, Novartis
Detlev Parow, Head Pharmaceutical Department, D.A.K.
Chris L Pashos, Vice President Of Global Evidence Strategy, AbbVie
Geert Pelsmaeker, General Manager, Leaphy
Marco Penske, Head Of Market Access And Health Care Affairs, Boehringer-Ingelheim
Dan Pettitt, Vice President Immunology Market Access And Policy Global Commercial Strategy Organization, Janssen Pharmaceuticals
Ed Pezalla, Former Vice President, National Medical Director For Pharmaceutical Policy And Strategy, Aetna
Andres Pichon Riviere, Executive Director And Director Of Health Technology Assessment And Economic Evaluations, I.E.C.S.
Lara Pippo, Head Of Market Access, C.S.L. Behring Spa
Adam Plich, Former Vice President, Head Of Pricing And Market Access Europe, Plich Advisory
Angelina Irizari Policarpio, Head Of Us Heor Field Team And Us Quality, Boehringer Ingelheim
Robert Popovian, Vice President Of Government Relations, Pfizer
Diann Potestio, Vice President Market Access, Ascendis Pharma